Objectives: The primary objective of this study will be to evaluate the impact of pre-emptive use of anakinra on the rate of severe cytokine release syndrome (…

B-Acute Lymphoblastic LeukemiaCAR-T Cell TherapyCytokine Release Syndrome+2 more

~Estimated

~$10 – $7,500

Kevin McNerneyNCT06703216

Observational

Multimodal Telerehabilitation in Patients Undergoing CAR-T Cell Immunotherapy

The proposed multimodal telerehabilitation model allows a rehabilitation therapy team to set up individualized rehabilitation plans using a web-based care mana…

LymphomaMyelomaCytokine Release Syndrome+1 more

~Estimated

~$10 – $6,250

University of UtahNCT07390071

Observational

Assessing the Performance of "DCog Short", an iPad-Based Tool for Neurotoxicity Evaluation in CAR-T Cell Therapy Patients: A Pilot Study

The aim of this study is to determine the effectiveness of DCog Short, a self-reporting, iPad-based application tool, in assessing neurotoxicity in participant…

NeurotoxicityNeurotoxicity SyndromesHematologic Malignancy+1 more

~Estimated

~$10 – $6,250

Beth Israel Deaconess Medical CenterNCT07403812